Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France

HPV and Gynecologic Cancer

Cervical Cancer Screening: Comparison of conventional Pap smear test, liquid-based cytology and human papillomavirus testing as stand-alone or co-testing strategies

Cancer Epidemiol Biomarkers Prev.

Liang LA, Einzmann T, Franzen A, Schwarzer K, Schauberger G, Schriefer D, Radde K, Zeissig SR, Ikenberg H, Meijer CJ, Kirkpatrick CJ, Kölbl H, Blettner M, Klug SJ

doi: 10.1158/1055-9965.EPI-20-1003.

HPV and Gynecologic Cancer

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

JAMA.

Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ

doi: 10.1001/jama.2018.7464.

HPV and Gynecologic Cancer

Modeling the balance of benefits and harms of cervical cancer screening with cytology and human papillomavirus testing

Cancer Epidemiol Biomarkers Prev.

Malagón T, Mayrand MH, Ogilvie G, Gotlieb WH, Blake J, Bouchard C, Franco EL, Kulasingam S

doi: 10.1158/1055-9965.EPI-20-0190.

HPV and Gynecologic Cancer

Predictive value of HPV testing in self-collected and clinician-collected samples compared with cytology in detecting high-grade cervical lesions

Cancer Epidemiol Biomarkers Prev.

El-Zein M, Bouten S, Louvanto K, Gilbert L, Gotlieb WH, Hemmings R, Behr MA, Franco EL

doi: 10.1158/1055-9965.EPI-18-1338

HPV and Gynecologic Cancer

Extended HPV genotyping to compare HPV type-distribution in self and provider-collected samples for cervical cancer screening

Cancer Epidemiol Biomarkers Prev.

Rohner E, Edelman C, Sanusi B, Schmitt JW, Baker A, Chesko K, Faherty B, Gregory SM, Romocki LS, Sivaraman V, Nelson JA, O'Connor S, Hudgens MG, Knittel AK, Rahangdale L, Smith JS

doi: 10.1158/1055-9965.EPI-20-0674.

HPV and Gynecologic Cancer

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program

JAMA Intern Med.

Wentzensen N, Clarke MA, Bremer R, Poitras N, Tokugawa D, Goldhoff PE, Castle PE, Schiffman M, Kingery JD, Grewal KK, Locke A, Kinney W, Lorey TS

doi: 10.1001/jamainternmed.

HPV and Gynecologic Cancer

Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement

JAMA.

US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng CW, Wong JB

doi: 10.1001/jama.2018.10897.

HPV and Gynecologic Cancer

HPV-vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level

Cancer Med.

Altobelli E, Rapacchietta L, Profeta VF, Fagnano R

doi: 10.1002/cam4.2048.

HPV and Gynecologic Cancer

Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.

Prev Med.

Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S

doi: 10.1016/j.ypmed.2016.11.029.

Related content

Cervical Cancer Screening: Comparison of conventional Pap smear test, liquid-based cytology and human papillomavirus testing as stand-alone or co-testing strategies

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

Modeling the balance of benefits and harms of cervical cancer screening with cytology and human papillomavirus testing

Predictive value of HPV testing in self-collected and clinician-collected samples compared with cytology in detecting high-grade cervical lesions

Extended HPV genotyping to compare HPV type-distribution in self and provider-collected samples for cervical cancer screening

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program

Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement

HPV-vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level

Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.